-
公开(公告)号：US08932628B2
公开(公告)日：2015-01-13
申请号：US11762343
申请日：2007-06-13
申请人： Werner Oberegger , Fang Zhou , Paul Maes , Graham Jackson , Mohammad Ashty Saleh
发明人： Werner Oberegger , Fang Zhou , Paul Maes , Graham Jackson , Mohammad Ashty Saleh
IPC分类号： A61K9/48 , A61K31/135 , A61K31/137 , A61K9/20 , C07C225/16 , A61K9/28
CPC分类号： A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要： The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US20130266650A1
公开(公告)日：2013-10-10
申请号：US13752102
申请日：2013-01-28
IPC分类号： A61K31/137
CPC分类号： A61K31/137 , A61K9/2013 , A61K9/284 , A61K9/2846 , A61K9/2866 , A61K9/2886
摘要： Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
摘要翻译： 描述了安非他酮氢溴酸盐制剂及其用于治疗病症的用途。
-
公开(公告)号：US07662407B2
公开(公告)日：2010-02-16
申请号：US11766251
申请日：2007-06-21
IPC分类号： A61K9/54 , A61K9/22 , A61K31/135
CPC分类号： A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要： The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
摘要翻译： 本发明涉及包含安非他酮盐的药物组合物，制剂和药物，特别是包含有效量的安非他酮氢溴酸盐的改性释放片剂，以及使用安非他酮盐来制备治疗病症的药物。
-
公开(公告)号：US20080038348A1
公开(公告)日：2008-02-14
申请号：US11762343
申请日：2007-06-13
申请人： Werner OBEREGGER , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty Saleh
发明人： Werner OBEREGGER , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty Saleh
IPC分类号： A61K9/24 , A61K31/135 , A61P25/00
CPC分类号： A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要： The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US07645901B2
公开(公告)日：2010-01-12
申请号：US11766213
申请日：2007-06-21
IPC分类号： C07C63/04
CPC分类号： A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要： The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US07579380B2
公开(公告)日：2009-08-25
申请号：US11774109
申请日：2007-07-06
申请人： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty Saleh
发明人： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty Saleh
IPC分类号： A61K31/12
CPC分类号： A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要： The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
摘要翻译： 本发明涉及包含安非他酮盐的药物组合物，制剂和药物，特别是包含有效量的安非他酮氢溴酸盐的改性释放片剂，以及使用安非他酮盐来制备治疗病症的药物。
-
公开(公告)号：US07572935B2
公开(公告)日：2009-08-11
申请号：US11762840
申请日：2007-06-14
IPC分类号： C07C63/08 , C07C49/80 , C07C225/10 , A61K31/136
CPC分类号： A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要： The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US07569611B2
公开(公告)日：2009-08-04
申请号：US11762820
申请日：2007-06-14
IPC分类号： A61K31/135
CPC分类号： A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要： The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US20100255094A1
公开(公告)日：2010-10-07
申请号：US12740223
申请日：2008-10-28
IPC分类号： A61K31/137 , A61K9/30 , A61P3/04 , A61P15/10 , A61P25/30 , A61P25/24 , A61P25/26 , A61P25/22
CPC分类号： A61K31/137 , A61K9/2013 , A61K9/284 , A61K9/2846 , A61K9/2866 , A61K9/2886
摘要： Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
-
公开(公告)号：US07645802B2
公开(公告)日：2010-01-12
申请号：US11930644
申请日：2007-10-31
IPC分类号： A61K31/135
CPC分类号： A61K31/137 , A61K9/2013 , A61K9/284 , A61K9/2846 , A61K9/2866 , A61K9/2886
摘要： Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
-
-
-
-
-
-
-
-
-
搜索结果
19 条记录 (耗时 0.061 秒)
